| P1-4 IA2030 Strategic Priority 7: Research & Innovation. Overview and goals | Kwaku Poku Asante | 2023 | Presentation | Anglais |
| P7 Optimizing vaccine regimens | Andrew Pollard, Kristen Earle | 2023 | Webinar | Anglais |
| W1 - Immunological and Vaccine Considerations for Special Populations: women of reproductive age and pregnancy, people living with HIV, and older adults | Carolyn Deal, Ruth Karron | 2023 | Webinar | Anglais |
| P3 - Current status of R&D for HIV, TB, Malaria, and Universal Influenza vaccines (and reports from Workshops 1-3) | Annie Mo, Jerome Kim | 2023 | Webinar | Anglais |
| W5 - Vaccine development strategies at the intersection of market model, value drivers, and access policy | Jessica Martinez, Raman Rao | 2023 | Webinar | Anglais |
| W7 - New vaccines on the horizon | Alejandro Cravioto, Shahida Baqar | 2023 | Webinar | Anglais |
| W8 - Select poster highlights | Peter Dull, Sinead Delany-Moretlwe | 2023 | Webinar | Anglais |
| W2 - Novel vaccine platforms | Max Silverman, Sue Ann Clemens | 2023 | Webinar | Anglais |
| P1 From GVAP to IA2030: roles of vaccine R&D to enable success | Lee Hall | 2023 | Webinar | Anglais |
| Keynote 2 - Future Pandemic R&D Preparedness in Korea and Translating Pandemic R&D Learnings into the Broader Global Health Agenda | Heechang Jang, Jerome Kim | 2023 | Webinar | Anglais |
| P8 - Reflections and closing remarks: Progress and the path forward | Noni MacDonald, Dalhousie U. | 2023 | Webinar | Anglais |
| GVIRF 2023 Welcome and Opening Remarks | Lee Hall | 2023 | Webinar | Anglais |
| P5 - Innovating to find and reach Zero-Dose Children | Samir Sodha | 2023 | Webinar | Anglais |
| Keynote 1 - Vaccines in the Post-COVID Era: Can Policy and Practice Keep up with Science | Barney Graham | 2023 | Webinar | Anglais |
| P2 - Lessons from COVID-19 vaccines and future pandemic preparedness | Charlie Weller | 2023 | Webinar | Anglais |
| P5-3 Using mHealth Interventions to Improve Vaccination Coverage | Abdul Momin Kazi | 2023 | Presentation | Anglais |
| P6 - Vaccine technologies for equity | Philippe-Alexandre Gilbert | 2023 | Webinar | Anglais |
| W4 - Mucosal immunity and vaccines | Melanie Saville | 2023 | Webinar | Anglais |
| W3 - Regional manufacturing | Martin Friede | 2023 | Webinar | Anglais |
| P6-3 A low footprint vaccine manufacturing platform for in-country, for-country production | Mathias Garny | 2023 | Presentation | Anglais |
| P5-4 Strengthening Routine Immunization: Use of Reaching Every District - Quality Improvement (RED-QI) approach | Melkamu Ayalew | 2023 | Presentation | Anglais |
| W8-9 Polyvalent strategy to the development of broadly protective vaccines against COVID-19 subvariants | Chang-Yuil Kang | 2023 | Presentation | Anglais |
| W8-8 The landscape of infectious disease exposure over the past two decades in the Kenyan coast | Timothy Chege | 2023 | Presentation | Anglais |
| W8-7 RV 460 Study: Comparative Adjuvant Study or HIV Env-C DNA and Protein Vaccines in Kenya | Josphat Kiprop Kosgei | 2023 | Presentation | Anglais |
| W8-6 Nucleoprotein Antigen Adjuvanted with Liposomal Cholesterol-linked TLR7/8 Agonist Showed Protective Immunity in Influenza Mouse Model | Chul Kim | 2023 | Presentation | Anglais |
| W8-4 Innovative DDS "DegradaBALL" for mRNA vaccine against next pandemics: "100 days mission" | Dal-Hee Min | 2023 | Presentation | Anglais |
| W8-5 Cross-neutralization of Influenza A by SARS-CoV-2 antibodies | Mohammad Mamun Alam | 2023 | Presentation | Anglais |
| W8-3 High prevalence of rotavirus infection among under five children despite a high rotavirus vaccination coverage in Ethiopia | Debasu Damtie | 2023 | Presentation | Anglais |
| W8-2 Changing the HPV Landscape with Indigenous Vaccine: CERVAVAC | Hitt Sharma | 2023 | Presentation | Anglais |
| W8-1 Workshop 8: Select Poster Highlights | Peter Dull | 2023 | Presentation | Anglais |
| W7-4 Enteric Disease: Shigella and ETEC Vaccine Development | Michelo Simuyandi | 2023 | Presentation | Anglais |
| W7-3 2023: the year of RSV | Ruth Karron | 2023 | Presentation | Anglais |
| W7-2 Dengue Vaccines | Annelies Wilder-Smith | 2023 | Presentation | Anglais |
| W6-5 Protecting young infants through immunoprevention | Jessica Fleming | 2023 | Presentation | Anglais |
| W6-4 Reaching adolescent girls with the HPV vaccine | Cathy Ndiaye | 2023 | Presentation | Anglais |
| W6-3 Implementation research needs on vaccine delivery according to epidemiological context | Halidou Tinto | 2023 | Presentation | Anglais |
| W6-1 What is implementation research and why is it important? | Alexander Rowe | 2023 | Presentation | Anglais |
| W5-5 Developing vaccines as global public good: RIGHT foundation’s approach | Hani Kim | 2023 | Presentation | Anglais |
| W5-4 The Next Frontier in Defining Value: Health Economics in LMICs | Alice Chen | 2023 | Presentation | Anglais |
| W4-6 A translational Research Institute focused on vaccines and airway immunity | Peter Andersen | 2023 | Presentation | Anglais |
| W4-5 mRNA-lipid nanoparticle vaccines for intranasal delivery | Darin Edwards | 2023 | Presentation | Anglais |
| W4-4 Adenovirus Vector Based Covid-19 Inhalation Vaccine | Chunlin Xin | 2023 | Presentation | Anglais |
| W4-3 A Mucosally-delivered Newcastle Disease Virus-vectored Booster Vaccine to Prevent SARS-CoV-2 Breakthrough Infection and Transmission | Michael Egan | 2023 | Presentation | Anglais |
| W4-2 Mucosal Immunity: What’s special about it and can vaccines induce it? | Peter Openshaw | 2023 | Presentation | Anglais |
| W4-1 Mucosal Immunity: Opening Remarks | Melanie Saville | 2023 | Presentation | Anglais |
| W3-5 The case for globally distributed vaccine manufacturing - CEPI perspective | Melanie Saville | 2023 | Presentation | Anglais |
| W2-3 mRNA and adjuvants friends…or foes ? | Nathalie Garcon | 2023 | Presentation | Anglais |
| W3-4 Gavi’s Strategy to Support Regional Manufacturing | Marta Tufet | 2023 | Presentation | Anglais |
| W3-3 Biological E. Limited | Mahima Datla | 2023 | Presentation | Anglais |
| W3-2 An African Mission - Establish and Sustain | Patrick Tippoo | 2023 | Presentation | Anglais |
